Affordable Access

deepdyve-link
Publisher Website

Triple subconjunctival bevacizumab injection for early corneal recurrent pterygium: one-year follow-up.

Authors
  • Nava-Castañeda, Angel
  • Ulloa-Orozco, Isabel
  • Garnica-Hayashi, Lilia
  • Hernandez-Orgaz, Joaquín
  • Jimenez-Martinez, Maria Carmen
  • Garfias, Yonathan
Type
Published Article
Journal
Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics
Publication Date
Mar 01, 2015
Volume
31
Issue
2
Pages
106–113
Identifiers
DOI: 10.1089/jop.2014.0060
PMID: 25369364
Source
Medline
License
Unknown

Abstract

The vascularized area in all recurrent pterygia and the corneal opacification area with this triple regimen of subconjunctival bevacizumab injections were reduced, which remained until the end of the study. These results suggest that bevacizumab subconjunctival injections could be useful to treat recurrent pterygium.

Report this publication

Statistics

Seen <100 times